Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2004. Start Trial.
Date Value
September 30, 2026 75.34%
August 31, 2026 75.34%
July 31, 2026 75.34%
June 30, 2026 75.34%
May 31, 2026 75.34%
April 30, 2026 75.34%
March 31, 2026 75.34%
February 28, 2026 75.34%
January 31, 2026 75.34%
December 31, 2025 75.34%
November 30, 2025 75.34%
October 31, 2025 75.34%
September 30, 2025 75.34%
August 31, 2025 75.34%
July 31, 2025 75.34%
June 30, 2025 75.34%
May 31, 2025 75.34%
April 30, 2025 75.34%
March 31, 2025 75.34%
February 28, 2025 75.34%
January 31, 2025 75.34%
December 31, 2024 75.34%
November 30, 2024 75.34%
October 31, 2024 75.34%
September 30, 2024 75.34%
Date Value
August 31, 2024 75.34%
July 31, 2024 75.34%
June 30, 2024 74.70%
May 31, 2024 72.83%
April 30, 2024 72.83%
March 31, 2024 72.83%
February 29, 2024 72.83%
January 31, 2024 72.83%
December 31, 2023 72.83%
November 30, 2023 72.83%
October 31, 2023 72.83%
September 30, 2023 63.81%
August 31, 2023 63.51%
July 31, 2023 63.51%
June 30, 2023 63.51%
May 31, 2023 59.82%
April 30, 2023 59.04%
March 31, 2023 55.43%
February 28, 2023 55.43%
January 31, 2023 55.43%
December 31, 2022 55.43%
November 30, 2022 55.43%
October 31, 2022 55.43%
September 30, 2022 55.43%
August 31, 2022 55.43%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Lifecore Biomedical, Inc. 89.19%
Sanofi 33.67%
Codexis, Inc. 97.65%
Nicox SA 96.28%
Evotec SE 94.17%